Associate Professor Steven Lane
Steven Lane is a clinical haematologist and translational researcher, based out of the Royal Brisbane and Women’s Hospital and QIMR Berghofer Medical Research Institute. His clinical work covers all aspects of benign and malignant haematology, with a specific focus on myeloid blood cancers such as AML, MDS and myeloproliferative neoplasm. He is the Director of Clinical Research in Cancer Care at RBWH, and a principal investigator on a number of national cooperative trials.
Steven is the Head of the Cancer Program at QIMR Berghofer, and lab head of the Gordon and Jessie Gilmour Leukaemia Research Lab. His lab researches myeloid blood cancers such as acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS) and the myeloproliferative neoplasms (MPN). These are very aggressive and rapidly fatal blood cancers that are among the most common types of cancer affecting Australians.
His efforts are concentrated on understanding how leukaemia stem cells in AML and MPN are able to regenerate leukaemia (or cause relapse in patients), even after cytotoxic chemotherapy. To achieve this, research has focused on generating robust models of leukaemia and dissecting the pathways of self-renewal in leukaemia stem cells and normal blood stem cells.
Steven has been fortunate to be awarded a CSL Centenary Fellowship (2017-21) and has previously received a Fulbright Scholarship and NHMRC Career Development Fellowship. His lab has also received support from NHMRC (continuous 2011-current), Cancer Australia, the Leukaemia Foundation and philanthropic donations. Steven is the Queensland Councillor and Treasurer for the Haematology Society of Australia and New Zealand.